logo

TRDA

Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)

TRDA fundamentals

Entrada Therapeutics (TRDA) released its earnings on Aug 6, 2025: revenue was 1.95M (YoY -97.94%), missed estimates; EPS was -1.04 (YoY -167.10%), missed estimates.
Revenue / YoY
1.95M
-97.94%
EPS / YoY
-1.04
-167.10%
Report date
Aug 6, 2025
EPS
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-9.78-0.89-0.69-0.74-0.8-0.79-0.21-0.781.02-0.290.681.55-0.350.03-0.42-1.04
Forecast
-0.87-1.285-0.655-0.725-0.76-0.8273-0.6512-0.6898-0.735-0.1684-0.5940.3614-0.728-0.6698-0.7886-0.8472
Surprise
-1024.14%
+30.74%
-5.34%
-2.07%
-5.26%
+4.51%
+67.75%
-13.08%
+238.78%
-72.21%
+214.48%
+328.89%
+51.92%
+104.48%
+46.74%
-22.76%
Revenue
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
00000025.26M18.17M43.73M41.85M59.12M94.69M19.57M37.40M20.56M1.95M
Forecast
0000007.00M9.78M9.60M23.69M14.98M51.86M12.32M13.12M10.17M9.65M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+260.86%
+85.86%
+355.69%
+76.66%
+294.75%
+82.60%
+58.83%
+185.04%
+102.12%
-79.80%

Earnings Call